Rationale and design of the Study of a Tele-pharmacy Intervention for Chronic diseases to Improve Treatment adherence (STIC2IT): A cluster-randomized pragmatic trial

American Heart Journal

Volumn 180, Issue , 2016, Pages 90-97

  Choudhry, Niteesh K ^a   Isaac, Thomas ^b   Lauffenburger, Julie C ^a   Gopalakrishnan, Chandrasekar ^a   Khan, Nazleen F ^a   Lee, Marianne ^b   Vachon, Amy ^b   Iliadis, Tanya L ^b   Hollands, Whitney ^b   Doheny, Scott ^b   Elman, Sandra ^b   Kraft, Jacqueline M ^b   Naseem, Samrah ^b   Gagne, Joshua J ^a   Jackevicius, Cynthia A ^c,d   Fischer, Michael A ^a   Solomon, Daniel H ^a   Sequist, Thomas D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Atrius Health   (United States)

^c WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; BILLING AND CLAIMS; CHRONIC DISEASE; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE CONTROL; FOLLOW UP; GROUP PRACTICE; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MEDICATION COMPLIANCE; MULTICENTER STUDY; PATIENT COMPLIANCE; PHARMACIST; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TELECONSULTATION; TELEPHONE; TEXT MESSAGING; TREATMENT REFUSAL; VIDEORECORDING; CLINICAL TRIAL; DIABETES MELLITUS; HYPERLIPIDEMIAS; HYPERTENSION; METHODOLOGY; PHARMACY; TELEMEDICINE;

CHRONIC DISEASE; DIABETES MELLITUS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; INTENTION TO TREAT ANALYSIS; MEDICATION ADHERENCE; PHARMACEUTICAL SERVICES; PROSPECTIVE STUDIES; RESEARCH DESIGN; TELEMEDICINE;

EID: 84984621750     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2016.07.017     Document Type: Article

References (35)

1. 1. Avorn, J, Monette, J, Lacour, A, et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA 279:18 (1998), 1458–1462.
2. 2. Benner, JS, Glynn, RJ, Mogun, H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 288:4 (2002), 455–461.
3. 3. Jackevicius, CA, Mamdani, M, Tu, JV, Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 288:4 (2002), 462–467.
4. 4. Choudhry, NK, Setoguchi, S, Levin, R, et al. Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients. Pharmacoepidemiol Drug Saf 17:12 (2008), 1189–1196.
5. 5. IMS Institute for Healthcare Informatics Avoidable Costs in US Health Care, http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Corporate/IMS%20Institute/RUOM-2013/IHII_Responsible_Use_Medicines_2013.pdf, 2013 [Accessed September 10, 2013.
6. 6. Benjamin, RM, Medication adherence: helping patients take their medicines as directed. Public Health Rep 127:1 (2012), 2–3.
7. 7. Osterberg, L, Blaschke, T, Adherence to medication. N Engl J Med 353:5 (2005), 487–497.
8. 8. Adherence to long-term therapies. 2003, World Health Organization.
9. 9. Viswanathan, M, Golin, CE, Jones, CD, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med 157:11 (2012), 785–795.
10. 10. Thakkar, J, Kurup, R, Laba, T-L, et al. Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis. JAMA Intern Med 176:3 (2016), 340–349.
11. 11. Wald, DS, Butt, S, Bestwick, JP, One-way versus two-way text messaging on improving medication adherence: meta-analysis of randomized trials. Am J Med 128:10 (2015), 1139.e1–1139.e5.
12. 12. Barker-Collo, S, Krishnamurthi, R, Witt, E, et al. Improving adherence to secondary stroke prevention strategies through motivational interviewing: randomized controlled trial. Stroke J Cereb Circ 46 (2015), 3451–3458.
13. 13. Hedegaard, U, Kjeldsen, LJ, Pottegård, A, et al. Improving medication adherence in patients with hypertension: a randomized trial. Am J Med 128 (2015), 1351–1361.
14. 14. Pfaeffli Dale, L, Whittaker, R, Jiang, Y, et al. Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. J Med Internet Res, 17(10), 2015, e237.
15. 15. Stewart, K, George, J, Mc Namara, KP, et al. A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial). J Clin Pharm Ther 39:5 (2014), 527–534.
16. 16. Cutrona, SL, Choudhry, NK, Fischer, MA, et al. Targeting cardiovascular medication adherence interventions. J Am Pharm Assoc JAPhA 52:3 (2012), 381–397.
17. 17. Nieuwlaat, R, Wilczynski, N, Navarro, T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev, 11, 2014, CD000011.
18. 18. American Diabetes Association, 5. Glycemic targets. Diabetes Care 39:Suppl 1 (2016), S39–S46.
19. 19. James, PA, Oparil, S, Carter, BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311:5 (2014), 507–520.
20. 20. Stone, NJ, Robinson, JG, Lichtenstein, AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129:25 Suppl 2 (2014), S1–45.
21. 21. Choudhry, NK, Shrank, WH, Levin, RL, et al. Measuring concurrent adherence to multiple related medications. Am J Manag Care 15:7 (2009), 457–464.
22. 22. Hibbard, JH, Stockard, J, Mahoney, ER, et al. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res 39:4 Pt 1 (2004), 1005–1026.
23. 23. Hibbard, JH, Mahoney, ER, Stockard, J, et al. Development and testing of a short form of the Patient Activation Measure. Health Serv Res 40:6 Pt 1 (2005), 1918–1930.
24. 24. Rollnick, S, Kinnersley, P, Stott, N, Methods of helping patients with behaviour change. BMJ 307:6897 (1993), 188–190.
25. 25. Heather, N, Rollnick, S, Bell, A, et al. Effects of brief counselling among male heavy drinkers identified on general hospital wards. Drug Alcohol Rev 15:1 (1996), 29–38.
26. 26. Samet, JH, Rollnick, S, Barnes, H, Beyond CAGE. A brief clinical approach after detection of substance abuse. Arch Intern Med 156:20 (1996), 2287–2293.
27. 27. Wilson, IB, Fowler, FJ, Cosenza, CA, et al. Cognitive and field testing of a new set of medication adherence self-report items for HIV care. AIDS Behav 18 (2014), 2349–2358.
28. 28. Newgard, CD, Lewis, RJ, Missing data: how to best account for what is not known. JAMA 314:9 (2015), 940–941.
29. 29. Glynn, RJ, Brookhart, MA, Stedman, M, et al. Design of cluster-randomized trials of quality improvement interventions aimed at medical care providers. Med Care 45:10 Supl 2 (2007), S38–S43.
30. 30. Choudhry, NK, Shrank, WH, Implementing randomized effectiveness trials in large insurance systems. J Clin Epidemiol 66:8 Suppl (2013), S5–11.
31. 31. Choudhry, NK, Shrank, WH, Four-dollar generics—increased accessibility, impaired quality assurance. N Engl J Med 363:20 (2010), 1885–1887.
32. 32. Lauffenburger, JC, Balasubramanian, A, Farley, JF, et al. Completeness of prescription information in US commercial claims databases. Pharmacoepidemiol Drug Saf 22:8 (2013), 899–906.
33. 33. Hansen, RA, Kim, MM, Song, L, et al. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother 43:3 (2009), 413–422.
34. 34. Lau, HS, de Boer, A, Beuning, KS, et al. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 50:5 (1997), 619–625.
35. 35. Schmittdiel, JA, Nichols, GA, Dyer, W, et al. Health care system-level factors associated with performance on Medicare STAR adherence metrics in a large, integrated delivery system. Med Care 53:4 (2015), 332–337.